Brief: Tenax Therapeutics Q1 Net Income USD -15.716 Million
May 12 (Reuters) - Tenax Therapeutics Q1 operating expenses USD 16.573 million. Q1 operating income USD -16.573 million
May 12 (Reuters) - Tenax Therapeutics Q1 operating expenses USD 16.573 million. Q1 operating income USD -16.573 million